EKOS launches two landmark clinical studies on pulmonary embolism

[News]

EKOS Corporation today announced the launch of two more landmark clinical studies named SEATTLE I & II, intended to further establish the safety and efficacy of its unique, ultrasound-accelerated thrombolysis in treating patients with life-threatening pulmonary embolism.

More... (http://www.news-medical.net/news/20120503/EKOS-launches-two-landmark-clinical-studies-on-pulmonary-embolism.aspx)